Split History
ETFs Holding TARO »    TARO Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Taro Pharmaceutical Industries is a multinational, science-based pharmaceutical company. Co. develops, manufactures and markets prescription and over-the-counter pharmaceutical products mainly in the U.S., Canada and Israel. Co.'s main focus includes semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories. Co. manufactures finished dosage form pharmaceutical products for sale in Israel and for export; and produces active pharmaceutical ingredients used in the manufacture of finished dosage form pharmaceutical products. According to our TARO split history records, Taro Pharmaceutical Industries has had 1 split.
TARO split history picture
Taro Pharmaceutical Industries (TARO) has 1 split in our TARO split history database. The split for TARO took place on July 27, 2001. This was a 2 for 1 split, meaning for each share of TARO owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following the split.

When a company such as Taro Pharmaceutical Industries splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.

Looking at the TARO split history from start to finish, an original position size of 1000 shares would have turned into 2000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Taro Pharmaceutical Industries shares, starting with a $10,000 purchase of TARO, presented on a split-history-adjusted basis factoring in the complete TARO split history. TARO split adjusted history picture

Growth of $10,000.00
With Dividends Reinvested

Start date: 02/04/2013
End date: 01/31/2023
Start price/share: $48.49
End price/share: $29.82
Starting shares: 206.23
Ending shares: 235.76
Dividends reinvested/share: $12.81
Total return: -29.70%
Average Annual Total Return: -3.46%
Starting investment: $10,000.00
Ending investment: $7,033.26
Years: 9.99
Growth of $10,000.00
Without Dividends Reinvested

Start date: 02/04/2013
End date: 01/31/2023
Start price/share: $48.49
End price/share: $29.82
Dividends collected/share: $12.81
Total return: -12.08%
Average Annual Total Return: -1.28%
Starting investment: $10,000.00
Ending investment: $8,791.89
Years: 9.99
Date Ratio
07/27/20012 for 1
TARO is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

TBRA Split History
TCON Split History
TEAR Split History
TECH Split History
TELK Split History
TENX Split History
TEVA Split History
TFX Split History
TGTX Split History
TGX Split History

Also explore: TARO shares outstanding history

Email EnvelopeFree TARO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Liminal BioSciences Inc. (LMNL)
Galway Metals Inc. (GWM.CA)
Lannett Company, Inc. (LCI)
Reed's, Inc. (REED)
Phio Pharmaceuticals Corp. (PHIO)
Swvl Holdings Corp (SWVL)
Sientra, Inc. (SIEN)
Eargo, Inc. (EAR)
Alterity Therapeutics Limited (ATHE)
Aytu BioPharma, Inc. (AYTU)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

TARO Split History | www.SplitHistory.com | Copyright © 2013 - 2023, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.